Bioxtreme Pharma Private Limited - Company Profile

It is a healthcare private limited company based in Panchkula, Haryana, India, established in 2021.
2021 Panchkula, Haryana, India Active
Last Updated:
About Bioxtreme Pharma Private Limited

Bioxtreme Pharma Private Limited, a active private limited company, was established on 15 April 2021 in Panchkula, Haryana, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U24230HR2021PTC094502. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Avadhesh Kumar Singh (Director), Kali Charan Jaiswal (Director). Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at P.No-315 1/A,P-Ii Panchkula, Panchkula, Haryana, 134113.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230HR2021PTC094502

  • Registration Number

    094502

  • Incorporation Date

    15 April 2021

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Net Worth 112.23%
  • Total Assets **** 10504.29%
Company report

Bioxtreme Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bioxtreme Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Bioxtreme Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Avadhesh Kumar Singh Director 15 Apr 2021 Current
Kali Charan Jaiswal Director 15 Apr 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bioxtreme Pharma.

Bioxtreme Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 112.23%.

Bioxtreme Pharma revenue growth over time
Bioxtreme Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
10504.29%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
112.23%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bioxtreme Pharma?

Unlock access to Bioxtreme Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Bioxtreme Pharma?

Bioxtreme Pharma has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bioxtreme Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioxtreme Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bioxtreme Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Bioxtreme Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Bioxtreme Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Avadhesh Kumar Singh was appointed as a Director was appointed as a Director on 15 Apr 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.

  • Director Appointment

    Progress on Kali Charan Jaiswal was appointed as a Director was appointed as a Director on 15 Apr 2021 & has been associated with this company since 4 years 10 months . was documented.

  • Company Incorporation

    Progress on Bioxtreme Pharma Private Limited was registered on 15 Apr 2021 with Roc Delhi & aged 4 years 10 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bioxtreme Pharma Private Limited?

The CIN of Bioxtreme Pharma Private Limited is U24230HR2021PTC094502.

Where is Bioxtreme Pharma Private Limited headquartered?

Bioxtreme Pharma Private Limited is headquartered at P.No-315 1/A,P-Ii Panchkula, Panchkula, Haryana, 134113.

When was Bioxtreme Pharma Private Limited incorporated?

Bioxtreme Pharma Private Limited was incorporated on 15 April 2021.

Who are the current directors of Bioxtreme Pharma Private Limited?

The current directors of Bioxtreme Pharma Private Limited are

What is the primary industry of Bioxtreme Pharma Private Limited?

The primary industry of Bioxtreme Pharma Private Limited is Trade.

Is Bioxtreme Pharma Private Limited a listed company?

Bioxtreme Pharma Private Limited is unlisted.

What is the capital structure of Bioxtreme Pharma Private Limited?

The authorized capital of Bioxtreme Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available